Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Next Generation Diabetes Therapy and Drug Delivery
1.2 Key Market Segments
1.2.1 Next Generation Diabetes Therapy and Drug Delivery Segment by Type
1.2.2 Next Generation Diabetes Therapy and Drug Delivery Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Next Generation Diabetes Therapy and Drug Delivery Market Overview
2.1 Global Market Overview
2.1.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Next Generation Diabetes Therapy and Drug Delivery Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Next Generation Diabetes Therapy and Drug Delivery Market Competitive Landscape
3.1 Global Next Generation Diabetes Therapy and Drug Delivery Sales by Manufacturers (2019-2024)
3.2 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Manufacturers (2019-2024)
3.3 Next Generation Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Next Generation Diabetes Therapy and Drug Delivery Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Next Generation Diabetes Therapy and Drug Delivery Sales Sites, Area Served, Product Type
3.6 Next Generation Diabetes Therapy and Drug Delivery Market Competitive Situation and Trends
3.6.1 Next Generation Diabetes Therapy and Drug Delivery Market Concentration Rate
3.6.2 Global 5 and 10 Largest Next Generation Diabetes Therapy and Drug Delivery Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Next Generation Diabetes Therapy and Drug Delivery Industry Chain Analysis
4.1 Next Generation Diabetes Therapy and Drug Delivery Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Next Generation Diabetes Therapy and Drug Delivery Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Next Generation Diabetes Therapy and Drug Delivery Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Next Generation Diabetes Therapy and Drug Delivery Sales Market Share by Type (2019-2024)
6.3 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Market Share by Type (2019-2024)
6.4 Global Next Generation Diabetes Therapy and Drug Delivery Price by Type (2019-2024)
7 Next Generation Diabetes Therapy and Drug Delivery Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Sales by Application (2019-2024)
7.3 Global Next Generation Diabetes Therapy and Drug Delivery Market Size (M USD) by Application (2019-2024)
7.4 Global Next Generation Diabetes Therapy and Drug Delivery Sales Growth Rate by Application (2019-2024)
8 Next Generation Diabetes Therapy and Drug Delivery Market Segmentation by Region
8.1 Global Next Generation Diabetes Therapy and Drug Delivery Sales by Region
8.1.1 Global Next Generation Diabetes Therapy and Drug Delivery Sales by Region
8.1.2 Global Next Generation Diabetes Therapy and Drug Delivery Sales Market Share by Region
8.2 North America
8.2.1 North America Next Generation Diabetes Therapy and Drug Delivery Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Next Generation Diabetes Therapy and Drug Delivery Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Next Generation Diabetes Therapy and Drug Delivery Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Johnson and Johnson
9.1.1 Johnson and Johnson Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.1.2 Johnson and Johnson Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.1.3 Johnson and Johnson Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.1.4 Johnson and Johnson Business Overview
9.1.5 Johnson and Johnson Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
9.1.6 Johnson and Johnson Recent Developments
9.2 Abbott Laboratories
9.2.1 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.2.2 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.2.4 Abbott Laboratories Business Overview
9.2.5 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
9.2.6 Abbott Laboratories Recent Developments
9.3 Medtronic
9.3.1 Medtronic Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.3.2 Medtronic Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.3.4 Medtronic Next Generation Diabetes Therapy and Drug Delivery SWOT Analysis
9.3.5 Medtronic Business Overview
9.3.6 Medtronic Recent Developments
9.4 Sanofi
9.4.1 Sanofi Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.4.2 Sanofi Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.4.4 Sanofi Business Overview
9.4.5 Sanofi Recent Developments
9.5 Novo Nordisk
9.5.1 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.5.2 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.5.4 Novo Nordisk Business Overview
9.5.5 Novo Nordisk Recent Developments
9.6 MannKind Corporation
9.6.1 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.6.2 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.6.4 MannKind Corporation Business Overview
9.6.5 MannKind Corporation Recent Developments
9.7 Enteris BioPharma
9.7.1 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.7.2 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.7.4 Enteris BioPharma Business Overview
9.7.5 Enteris BioPharma Recent Developments
9.8 Dexcom
9.8.1 Dexcom Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.8.2 Dexcom Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.8.4 Dexcom Business Overview
9.8.5 Dexcom Recent Developments
9.9 Senseonics
9.9.1 Senseonics Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.9.2 Senseonics Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.9.4 Senseonics Business Overview
9.9.5 Senseonics Recent Developments
9.10 Medtech
9.10.1 Medtech Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.10.2 Medtech Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.10.4 Medtech Business Overview
9.10.5 Medtech Recent Developments
9.11 Synertech
9.11.1 Synertech Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.11.2 Synertech Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.11.4 Synertech Business Overview
9.11.5 Synertech Recent Developments
9.12 Zosano Pharma
9.12.1 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.12.2 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.12.4 Zosano Pharma Business Overview
9.12.5 Zosano Pharma Recent Developments
9.13 Relmada Therapeutics
9.13.1 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.13.2 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.13.4 Relmada Therapeutics Business Overview
9.13.5 Relmada Therapeutics Recent Developments
9.14 Eli Lilly and Company
9.14.1 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.14.2 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.14.4 Eli Lilly and Company Business Overview
9.14.5 Eli Lilly and Company Recent Developments
9.15 Transdermal Specialties
9.15.1 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Basic Information
9.15.2 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Product Overview
9.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Product Market Performance
9.15.4 Transdermal Specialties Business Overview
9.15.5 Transdermal Specialties Recent Developments
10 Next Generation Diabetes Therapy and Drug Delivery Market Forecast by Region
10.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast
10.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast by Country
10.2.3 Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast by Region
10.2.4 South America Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Next Generation Diabetes Therapy and Drug Delivery by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Next Generation Diabetes Therapy and Drug Delivery by Type (2025-2030)
11.1.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Next Generation Diabetes Therapy and Drug Delivery by Type (2025-2030)
11.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Forecast by Application (2025-2030)
11.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Sales (K Units) Forecast by Application
11.2.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
